SCHEMBL5169171

SCHEMBL5169171

CN(C)CC1CCC/C(=C/c2ccccc2)C1(O)Cc1cccc(F)c1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
OPRK1 P41145 6/20 0.37
OPRD1 P41143 6/20 0.37
SLC6A4 P31645 8/20 0.36
SLC6A2 P23975 7/20 0.36
OPRM1 P35372 6/20 0.36
KMT2A Q03164 4/20 0.36
MEN1 O00255 3/20 0.36
OPRL1 P41146 1/20 0.35
TAAR1 Q96RJ0 1/20 0.35
SLC22A1 O15245 2/20 0.35
CHRM2 P08172 1/20 0.35
CHRM1 P11229 1/20 0.35
HTR1A P08908 1/20 0.35
STS P08842 1/20 0.33
SLC6A3 Q01959 1/20 0.33
TRPA1 O75762 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5168117 1.00 OPRK1 (0.37) OPRK1OPRD1SLC6A4SLC6A2OPRM1
SCHEMBL5170890 0.97 SLC6A4 (0.38) OPRK1OPRD1SLC6A4SLC6A2OPRM1
SCHEMBL5169690 0.97 SLC6A4 (0.38) OPRK1OPRD1SLC6A4SLC6A2OPRM1
SCHEMBL5169614 0.94 OPRD1 (0.38) OPRK1OPRD1SLC6A4SLC6A2OPRM1
SCHEMBL5171402 0.94 OPRD1 (0.38) OPRK1OPRD1SLC6A4SLC6A2OPRM1
SCHEMBL5170433 0.92 OPRD1 (0.35) OPRK1OPRD1SLC6A4SLC6A2OPRM1
SCHEMBL5170427 0.92 OPRD1 (0.35) OPRK1OPRD1SLC6A4SLC6A2OPRM1
SCHEMBL5170869 0.90 SLC6A2 (0.38) OPRK1OPRD1SLC6A4SLC6A2OPRM1
SCHEMBL5170872 0.90 SLC6A2 (0.38) OPRK1OPRD1SLC6A4SLC6A2OPRM1
SCHEMBL5170601 0.89 SLC6A2 (0.35) OPRK1OPRD1SLC6A4SLC6A2OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1322590-B1 5-AMINO-1-PENTENE-3-OL SUBSTITUTED DERIVATIVES GRUENENTHAL GMBH (DE) 2007-05-02 EP claimed
US-6815443-B2 CARBOCYCLIC OXY AMINES SUCH AS 2-BENZYLIDENE-6-DIMETHYLAMINO METHYLCYCLOHEXANONE, USED AS ANALGESICS GRUENENTHAL GMBH (DE) 2004-11-09 US claimed
US-20030220390-A1 5-Amino-1-pentene-3-ol substituted derivatives GRUENENTHAL GMBH (DE) 2003-11-27 US claimed
US-6815443-B2 CARBOCYCLIC OXY AMINES SUCH AS 2-BENZYLIDENE-6-DIMETHYLAMINO METHYLCYCLOHEXANONE, USED AS ANALGESICS GRUENENTHAL GMBH (DE) 2004-11-09 US disclosed
US-20030220390-A1 5-Amino-1-pentene-3-ol substituted derivatives GRUENENTHAL GMBH (DE) 2003-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030220390-A1 5-Amino-1-pentene-3-ol substituted derivatives ALOX5, PGA5, ANXA5 OPRK1 146/4885OPRD1 211/4885SLC6A4 1810/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.